BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38657099)

  • 1. Comprehensive genetic profiling reveals frequent alterations of driver genes on the X chromosome in extranodal NK/T-cell lymphoma.
    Ito Y; Marouf A; Kogure Y; Koya J; Liévin R; Bruneau J; Tabata M; Saito Y; Shingaki S; Yuasa M; Yamaguchi K; Murakami K; Weil R; Vavasseur M; Andrieu GP; Latiri M; Veleanu L; Dussiot M; André I; Joshi A; Lagresle-Peyrou C; Magerus A; Chaubard S; Lavergne D; Bachy E; Brunet E; Fataccioli V; Brouzes C; Laurent C; De Leval L; Traverse-Glehen A; Bossard C; Parrens MC; Meignin V; Philippe L; Rossignol J; Suarez F; Michot JM; Tournilhac O; Damaj G; Lemonnier F; Bôle-Feysot C; Nitschké P; Tesson B; Laurent C; Molina T; Asnafi V; Watatani Y; Chiba K; Okada A; Shiraishi Y; Tsukita S; Izutsu K; Miyoshi H; Ohshima K; Sakata S; Dobashi A; Takeuchi K; Sanada M; Gaulard P; Jaccard A; Ogawa S; Hermine O; Kataoka K; Couronné L
    Cancer Res; 2024 Apr; ():. PubMed ID: 38657099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EBV and the Pathogenesis of NK/T Cell Lymphoma.
    Montes-Mojarro IA; Fend F; Quintanilla-Martinez L
    Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33808787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational profile and EBV strains of extranodal NK/T-cell lymphoma, nasal type in Latin America.
    Montes-Mojarro IA; Chen BJ; Ramirez-Ibarguen AF; Quezada-Fiallos CM; Pérez-Báez WB; Dueñas D; Casavilca-Zambrano S; Ortiz-Mayor M; Rojas-Bilbao E; García-Rivello H; Metrebian MF; Narbaitz M; Barrionuevo C; Lome-Maldonado C; Bonzheim I; Fend F; Steinhilber J; Quintanilla-Martinez L
    Mod Pathol; 2020 May; 33(5):781-791. PubMed ID: 31822801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum EBV EA-IgA and VCA-IgA antibodies can be used for risk group stratification and prognostic prediction in extranodal NK/T cell lymphoma: 24-year experience at a single institution.
    Huang Y; Rao H; Yan S; Wang F; Wu Q; Feng Y; Zhang Y
    Ann Hematol; 2017 Aug; 96(8):1331-1342. PubMed ID: 28550598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequent mutations in HLA and related genes in extranodal NK/T cell lymphomas.
    Polprasert C; Takeuchi Y; Makishima H; Wudhikarn K; Kakiuchi N; Tangnuntachai N; Assanasen T; Sitthi W; Muhamad H; Lawasut P; Kongkiatkamon S; Bunworasate U; Izutsu K; Shiraishi Y; Chiba K; Tanaka H; Miyano S; Ogawa S; Yoshida K; Rojnuckarin P
    Leuk Lymphoma; 2021 Jan; 62(1):95-103. PubMed ID: 32964767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and immunohistochemical profiling of NK/T-cell lymphomas reveals prognostically relevant BCOR-MYC association.
    Oishi N; Satou A; Miyaoka M; Kawashima I; Segawa T; Miyake K; Mochizuki K; Kirito K; Feldman AL; Nakamura N; Kondo T
    Blood Adv; 2023 Jan; 7(1):178-189. PubMed ID: 35882439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of the Epstein-Barr virus to the oncogenesis of mature T-cell lymphoproliferative neoplasms.
    Barros MHM; Alves PDS
    Front Oncol; 2023; 13():1240359. PubMed ID: 37781191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rare case of low-grade extranodal NK/T-cell lymphoma, nasal type, arising in the setting of chronic rhinosinusitis and harboring a novel N-terminal KIT mutation.
    Devins K; Schuster SJ; Caponetti GC; Bogusz AM
    Diagn Pathol; 2018 Nov; 13(1):92. PubMed ID: 30470245
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus-negative extranodal "true" natural killer-cell lymphoma harbouring a KDM6A mutation.
    Tsuyama N; Asaka R; Dobashi A; Baba S; Mishima Y; Ueda K; Oguchi M; Tsuji H; Hatake K; Takeuchi K
    Hematol Oncol; 2018 Feb; 36(1):328-335. PubMed ID: 28695659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinicopathologic and molecular features in cutaneous extranodal natural killer-/T-cell lymphoma, nasal type, with aggressive and indolent course.
    Fried I; Artl M; Cota C; Müller H; Bartolo E; Boi S; Chiarelli C; Vale E; Schmuth M; Wiesner T; Speicher MR; Cerroni L
    J Am Acad Dermatol; 2014 Apr; 70(4):716-723. PubMed ID: 24433873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [CD16 expression is an independent prognostic factor for extranodal NK/T cell lymphoma of nasal type].
    Zuo Z; Yang QP; Tang Y; Zhao S; Yu JB; Liu YM; Gao LM; Liu WP
    Zhonghua Bing Li Xue Za Zhi; 2013 Apr; 42(4):227-33. PubMed ID: 23928528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of genomic alterations in Epstein-Barr virus-positive and Epstein-Barr virus-negative diffuse large B-cell lymphoma.
    Liu F; Tian S; Liu Q; Deng Y; He Q; Shi Q; Chen G; Xu X; Yuan J; Nakamura S; Karube K; Wang Z
    Cancer Med; 2024 Feb; 13(4):e6995. PubMed ID: 38457199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-Wide Analysis of Epstein-Barr Virus Isolated from Extranodal NK/T-Cell Lymphoma, Nasal Type.
    Lin N; Ku W; Song Y; Zhu J; Lu Z
    Oncologist; 2019 Sep; 24(9):e905-e913. PubMed ID: 30940744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological features and EBV infection status of lymphoma in children and adolescents in South China: a retrospective study of 662 cases.
    Qin C; Huang Y; Feng Y; Li M; Guo N; Rao H
    Diagn Pathol; 2018 Feb; 13(1):17. PubMed ID: 29482573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum B-cell activating factor predicts prognosis in nasal type, extranodal NK/T cell lymphoma.
    Zhang L; Li N; Yang L; Zhang J; Weng HW; Zou LQ
    Cytokine; 2016 Dec; 88():196-198. PubMed ID: 27668971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic profiling identifies distinct genetic subtypes in extra-nodal natural killer/T-cell lymphoma.
    Dong G; Liu X; Wang L; Yin W; Bouska A; Gong Q; Shetty K; Chen L; Sharma S; Zhang J; Lome-Maldonado C; Quintanilla-Martinez L; Li Y; Song JY; Zhang W; Shi Y; Wang J; Kong L; Wu X; Wang J; Liu HG; Kong L; Sun W; Liu W; Wang L; McKeithan TW; Iqbal J; Chan WC
    Leukemia; 2022 Aug; 36(8):2064-2075. PubMed ID: 35697790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aberrant Expression of Prohibitin Is Related to Prognosis of Nasal Extranodal Natural Killer/T Cell Lymphoma, Nasal Type.
    Guo WW; Chen LH; Yin W; Mo LX
    Oncol Res Treat; 2020; 43(10):491-497. PubMed ID: 32756049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The correlation of clinicopathological features and prognosis in extranodal natural killer/T cell lymphoma: a report of 42 cases in the early stage.
    Zeng L; Huang W; Cao Z; Zheng B; Liu X; Guo L; Feng X
    Ann Hematol; 2019 Jun; 98(6):1467-1476. PubMed ID: 30895352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel prognostic model based on ferritin and nomogram-revised risk index could better stratify patients with extranodal natural killer/T-cell lymphoma.
    Liu X; Liang Y; Shen Z; Wei L; Yang J; Piao Y; Sang W; Li P; Wang L
    Cancer Med; 2023 May; 12(9):10660-10671. PubMed ID: 36924334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extranodal NK/T cell lymphoma, nasal type: An updated overview.
    Sánchez-Romero C; Bologna-Molina R; Paes de Almeida O; Santos-Silva AR; Prado-Ribeiro AC; Brandão TB; Carlos R
    Crit Rev Oncol Hematol; 2021 Mar; 159():103237. PubMed ID: 33493634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.